Kymera
showed meaningful signs of clinical activity in comparing favorably to placebo and soc summary results | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
59 of 63
Similar slides by Kymera
See diffirences between slides (animation)
Investor Presentation
December 2023
showed meaningful signs of clinical activity in comparing favorably to placebo and soc | Kymera
Investor Presentation
December 2023
showed meaningful signs of clinical activity in comparing favorably to placebo and soc | Kymera
Investor Presentation
November 2023
showed meaningful signs of clinical activity in comparing favorably to placebo and soc | Kymera
Investor Presentation
November 2023
showed meaningful signs of clinical activity in comparing favorably to placebo and soc | Kymera
Related slides by other companies
MindMed
Investor Presentation
November 2024
continued response and remission through week with clinical responder rate and clinical remission rate | MindMed
MindMed
Investor Presentation
December 2024
continued response and remission through week with clinical responder rate and clinical remission rate | MindMed
Aeglea BioTherapeutics
Investor Presentation
April 2023
peace phase trial marked and sustained reduction in plasma arginine | Aeglea BioTherapeutics
AstraZeneca
Investor Day
January 2022
response | AstraZeneca
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights